Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,485 | 6,575 | 6,974 | 7,334 | 10,345 |
| Marketable Securities | N/A | N/A | N/A | N/A | 500 |
| TOTAL | $5,653 | $7,268 | $7,547 | $8,025 | $11,741 |
| Non-Current Assets | |||||
| PPE Net | 156 | 158 | 450 | 468 | 1,648 |
| Intangibles | 0 | 0 | 0 | 0 | 1,336 |
| Other Non-Current Assets | 3,886 | 3,998 | 4,038 | 4,148 | 5,852 |
| TOTAL | $4,042 | $4,156 | $4,488 | $4,616 | $8,836 |
| Total Assets | $9,695 | $11,424 | $12,035 | $12,641 | $20,577 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 80 | 167 | 282 | 95 | 349 |
| Accrued Expenses | 564 | 795 | 1,179 | 1,805 | 1,037 |
| TOTAL | $1,495 | $1,784 | $2,255 | $2,666 | $2,124 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,472 | 1,697 | 3,242 | 2,116 | 2,319 |
| TOTAL | $1,740 | $1,965 | $3,510 | $2,385 | $2,674 |
| Total Liabilities | $3,235 | $3,749 | $5,765 | $5,051 | $4,798 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,406 | 5,087 | 5,087 | 5,087 | 5,087 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -208,875 | -206,725 | -201,480 | -199,824 | -191,391 |
| TOTAL | $6,460 | $7,675 | $6,270 | $7,590 | $15,779 |
| Total Liabilities And Equity | $9,695 | $11,424 | $12,035 | $12,641 | $20,577 |